Xeris Biopharma Holdings, Inc. (XERS) Stock Price History
Historical prices from 2018 to 2026
Loading 10-year price history...
XERS Historical Performance
Short-Term Returns
XERS Stock Price Trajectory (2018–2026)
As of May 8, 2026, Xeris Biopharma Holdings, Inc. (XERS) trades at $6.63, representing a +48.0% return over the past year. The stock has delivered a +104.0% total return over five years (+15.3% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $27.98 on September 12, 2018. From this peak, XERS has corrected -76.3%, currently trading 6% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers LNTH (+13.1% 1Y), SUPN (+69.0% 1Y), and PAHC (+122.6% 1Y), XERS has underperformed the peer group average. Compare XERS vs LNTH →
XERS Historical Price Data (2025–2026)
Showing 30 of 1,981 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 6.62 | 7.00 | 6.19 | 6.63 | 5.52M | +4.08% |
| 2026-05-06 | 6.29 | 6.44 | 6.16 | 6.37 | 1.92M | +2.25% |
| 2026-05-05 | 6.39 | 6.46 | 6.21 | 6.23 | 1.34M | -1.74% |
| 2026-05-04 | 6.20 | 6.40 | 6.19 | 6.34 | 862K | +0.96% |
| 2026-05-01 | 6.17 | 6.33 | 6.10 | 6.28 | 1.38M | +2.53% |
| 2026-04-30 | 6.02 | 6.21 | 6.02 | 6.13 | 998K | +1.74% |
| 2026-04-29 | 6.01 | 6.08 | 5.97 | 6.02 | 1.04M | -1.15% |
| 2026-04-28 | 6.09 | 6.17 | 6.01 | 6.09 | 929K | -0.49% |
| 2026-04-27 | 6.04 | 6.17 | 6.02 | 6.12 | 888K | +1.16% |
| 2026-04-24 | 5.98 | 6.07 | 5.89 | 6.05 | 1.00M | +1.68% |
| 2026-04-23 | 6.04 | 6.07 | 5.90 | 5.95 | 1.13M | -1.49% |
| 2026-04-22 | 5.93 | 6.06 | 5.83 | 6.04 | 1.37M | +2.55% |
| 2026-04-21 | 6.25 | 6.29 | 5.87 | 5.89 | 1.96M | -5.61% |
| 2026-04-20 | 6.31 | 6.36 | 6.18 | 6.24 | 1.45M | -2.04% |
| 2026-04-17 | 6.26 | 6.41 | 6.17 | 6.37 | 1.24M | +4.08% |
| 2026-04-16 | 6.21 | 6.27 | 6.09 | 6.12 | 1.38M | -1.29% |
| 2026-04-15 | 6.08 | 6.22 | 6.05 | 6.20 | 1.02M | +2.14% |
| 2026-04-14 | 6.04 | 6.17 | 5.97 | 6.07 | 1.07M | +1.68% |
| 2026-04-13 | 5.81 | 6.03 | 5.78 | 5.97 | 1.16M | +2.05% |
| 2026-04-10 | 6.03 | 6.08 | 5.76 | 5.85 | 942K | -2.66% |
| 2026-04-09 | 5.81 | 6.05 | 5.75 | 6.01 | 1.57M | +1.52% |
| 2026-04-08 | 6.13 | 6.18 | 5.91 | 5.92 | 2.20M | +0.85% |
| 2026-04-07 | 6.01 | 6.08 | 5.87 | 5.87 | 1.62M | -2.98% |
| 2026-04-06 | 6.08 | 6.14 | 5.97 | 6.05 | 860K | +0.17% |
| 2026-04-02 | 5.88 | 6.14 | 5.88 | 6.04 | 1.31M | 0.00% |
| 2026-04-01 | 5.89 | 6.10 | 5.86 | 6.04 | 2.27M | +4.14% |
| 2026-03-31 | 5.69 | 5.92 | 5.68 | 5.80 | 1.99M | +3.57% |
| 2026-03-30 | 5.33 | 5.64 | 5.29 | 5.60 | 2.51M | +3.70% |
| 2026-03-27 | 5.55 | 5.55 | 5.35 | 5.40 | 1.28M | -3.05% |
| 2026-03-26 | 5.26 | 5.66 | 5.26 | 5.57 | 2.12M | +5.09% |
See XERS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XERS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XERS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXERS — Frequently Asked Questions
Quick answers to the most common questions about buying XERS stock.
How has XERS stock performed recently?
XERS returned +48.0% over the past year, beating its 5-year annualized CAGR of +15.3%. The stock trades below its 200-day moving average, confirming the uptrend.
What is XERS's all-time high price?
Xeris Biopharma Holdings, Inc. reached $27.98 on 2018-09-12. The 52-week high is $10.08. Current 1-year return of +48.0% places the stock closer to historical peaks.
Where can I download XERS historical price data?
This page provides XERS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.